Johnson & Johnson Innovation LLC opened JLABS @ TMC, a new 34,000-square foot life sciences incubator providing entrepreneurs shared lab space, private offices, and modular laboratory suites, as well as equipment and value-added operational, education, and business services. The new JLABS facility can accommodate up to 50 startups and will open with 21 companies that represent a range of disciplines and geographies.

JLABS @ TMC builds on the JLABS model and is the fifth JLABS facility to open in the United States. The Houston site is the first to open with a medical device prototype lab, including a 3D printer, which will provide entrepreneurs access to specialized tools, as well as skills building programs to design and develop smart health technologies.

JLABS @ TMC is housed within the TMC Innovation Institute, adjacent to TMC's life sciences accelerator TMCx, enhancing its “think tank” –like environment and encouraging sharing of ideas, collaboration among JLABS, TMC and TMCx residents, and facilitation of relationships with investors and venture capitalists.

JLABS @ TMC joins a network of facilities that are based throughout North America in life science clusters, including San Diego (flagship), San Francisco, South San Francisco, Boston and, opening this spring, the first international location in Toronto, Canada. These facilities are currently home to more than 100 early-stage companies advancing bio/pharmaceutical, medical device, consumer and digital health programs. The JLABS facilities will have a total capacity for 225 resident companies once all six are open and operational.

Source: Johnson & Johnson